SciClone Pharmaceuticals (United States)
- Research works
- 102 ▼ 15% vs 2013–17
- Citations
- 4.6k 45.5 per fractional work
- Top-10% rate
- 5.9% record average 16.5%
- Open access
- 23% world 28%
Not ranked overall: SciClone Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 13.7×. Every wedge is a field page.
Who are the top researchers at SciClone Pharmaceuticals (United States)?
Ranked on the composite score, James R. Tonra and Andrew Santangelo lead among researchers whose main affiliation is SciClone Pharmaceuticals (United States).
- 1 James R. Tonra United States · #743,399 worldwide 50 citations · 26 works
- 2 Andrew Santangelo United States · #776,736 worldwide 9 citations · 22 works
Which keywords describe research at SciClone Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Thermal Analysis, CubeSat, small satellite, Inflammation, Glycosylation, Monoclonal Antibodies, Cancer and Therapeutic Antibodies.
- Stability
- Tumor Regression
- Trastuzumab
- Targeted Therapy
- On-Orbit Servicing
- Monoclonal Antibody
- Cell Migration
- Cell Signaling
- Toll-like Receptors
- Innate Immunity
- Neurotoxicity
- Immunity
- Chemotherapy
- VEGF
- Antibody Engineering
- Therapeutic Antibodies
- LEO Satellite Constellation
- Glycosylation
- small satellite
- Thermal Analysis
- Inflammation
- CubeSat
- Cancer
- Monoclonal Antibodies
- Satellite Communications
- Angiogenesis
- Fc Receptors
- endothelial progenitor cells
- Tumor Microenvironment
- Metabolism
- Chemotherapy-Induced Peripheral Neuropathy
- Taxanes
- Cancer Therapy
- Cancer Immunotherapy
- Biopharmaceuticals
- Extracellular Matrix
- Space Debris
- Recombinant Proteins
- Distributed Systems
- Cancer Progression
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation10▲ 4.3×25 topics
- Thermal Analysis9▲ 58×2 topics
- CubeSat8▲ 333×1 topic
- small satellite8▲ 333×1 topic
- Cancer8▲ 5.8×18 topics
- Glycosylation7▲ 33×3 topics
- Monoclonal Antibodies7▲ 49×3 topics
- LEO Satellite Constellation7▲ 341×1 topic
- Satellite Communications7▲ 341×1 topic
- Therapeutic Antibodies7▲ 54×2 topics
- Angiogenesis6▲ 14×10 topics
- Antibody Engineering5▲ 53×1 topic
- Fc Receptors5▲ 53×1 topic
- VEGF5▲ 150×1 topic
- endothelial progenitor cells5▲ 150×1 topic
- Chemotherapy5▲ 6.5×10 topics
- Tumor Microenvironment4▲ 9.9×6 topics
- Immunity4▲ 10×5 topics
- Metabolism4▲ 5.3×4 topics
- Neurotoxicity3▲ 17×2 topics
- Chemotherapy-Induced Peripheral Neuropathy3▲ 55×1 topic
- Innate Immunity3▲ 7.8×4 topics
- Taxanes3▲ 55×1 topic
- Toll-like Receptors3▲ 17×3 topics
- Cancer Therapy3▲ 4.2×9 topics
- Cell Signaling3▲ 7.9×6 topics
- Cancer Immunotherapy2▲ 18×2 topics
- Cell Migration2▲ 28×3 topics
- Biopharmaceuticals2▲ 33×3 topics
- Monoclonal Antibody2▲ 33×2 topics
- Extracellular Matrix2▲ 9.1×3 topics
- On-Orbit Servicing2▲ 107×1 topic
- Space Debris2▲ 107×1 topic
- Targeted Therapy2▲ 9.8×4 topics
- Recombinant Proteins2▲ 39×2 topics
- Trastuzumab2▲ 47×2 topics
- Distributed Systems2▲ 8.0×2 topics
- Tumor Regression2▲ 22×2 topics
- Cancer Progression2▲ 8.3×3 topics
- Stability2▲ 9.9×2 topics
Which research topics does SciClone Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Cancer Treatment and Pharmacology, Spacecraft Design and Technology, Distributed systems and fault tolerance and Space Satellite Systems and Control.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Treatment and Pharmacology Oncology 1 works
- 2 Spacecraft Design and Technology Aerospace Engineering 0 works
- 3 Distributed systems and fault tolerance Computer Networks and Communications 0 works
- 4 Space Satellite Systems and Control Aerospace Engineering 0 works
- 5 Pediatric Hepatobiliary Diseases and Treatments Surgery 0 works
- 6 Immune cells in cancer Immunology 0 works
- 7 Immune responses and vaccinations Immunology 0 works
- 8 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 9 Drug Transport and Resistance Mechanisms Oncology 0 works
- 10 Intestinal Malrotation and Obstruction Disorders Surgery 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has SciClone Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 15% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Foster City
- Gilead Sciences (United States)
- Visa (United States)
- Interdisciplinary Dental Education Academy
- Notable Labs (United States)
- TeraRecon (United States)
- Guidewire (United States)
- Apollomics (United States)
- Active Spectrum (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.